-
K. M. Lee
Ophthalmology, Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Department of Ophthalmology, College of Medicine, Seoul National University & Seoul Artificial Eye Center Clinical Research Institute, Seoul National University Hospital, Seoul, Korea, Seoul, Republic of Korea
-
J. H. Kim
Ophthalmology, Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Department of Ophthalmology, College of Medicine, Seoul National University & Seoul Artificial Eye Center Clinical Research Institute, Seoul National University Hospital, Seoul, Korea, Seoul, Republic of Korea
-
J. H. Kim
Ophthalmology, Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Department of Ophthalmology, College of Medicine, Seoul National University & Seoul Artificial Eye Center Clinical Research Institute, Seoul National University Hospital, Seoul, Korea, Seoul, Republic of Korea
-
E. Yang
Ophthalmology, Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Department of Ophthalmology, College of Medicine, Seoul National University & Seoul Artificial Eye Center Clinical Research Institute, Seoul National University Hospital, Seoul, Korea, Seoul, Republic of Korea
-
K.-W. Kim
NeuroVascular Corrdination Research Center, College of pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea, Seoul, Republic of Korea
-
Y. S. Yu
Ophthalmology, Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Department of Ophthalmology, College of Medicine, Seoul National University & Seoul Artificial Eye Center Clinical Research Institute, Seoul National University Hospital, Seoul, Korea, Seoul, Republic of Korea